Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Total Non-Current Liabilities (2022 - 2023)

iBio (IBIO) has disclosed Total Non-Current Liabilities for 2 consecutive years, with $24.2 million as the latest value for Q3 2023.

  • On a quarterly basis, Total Non-Current Liabilities changed N/A to $24.2 million in Q3 2023 year-over-year; TTM through Sep 2023 was $24.2 million, a N/A change, with the full-year FY2023 number at $25.3 million, changed N/A from a year prior.
  • Total Non-Current Liabilities was $24.2 million for Q3 2023 at iBio, down from $25.3 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $31.9 million in Q4 2022 to a low of $24.2 million in Q3 2023.